Last updated on February 2018

Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)


Brief description of study

The purpose of this study is to assess the safety and performance of the Trialign System for the treatment of symptomatic chronic functional tricuspid regurgitation (FTR) in patients with a minimum of moderate tricuspid regurgitation.

The procedure will be performed with the PTVAS device using a non-surgical percutaneous approach to tricuspid valve repair in patients who have FTR with a minimum of moderate tricuspid regurgitation.

Detailed Study Description

A prospective, single-arm, multi-center study, enrolling symptomatic patients with chronic functional tricuspid regurgitation. The study will include up to 60 subjects from up to 15 sites in Europe and the United States. Follow-up evaluations will be conducted through 5 years post implantation.

Clinical Study Identifier: NCT03225612

Contact Investigators or Research Sites near you

Start Over

Christian Butter, MD

Herzzentrum Brandenburg in Bernau
Bernau bei Berlin, Germany
  Connect »